| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MIB.2012.05.012 |
| P698 | PubMed publication ID | 22770659 |
| P2093 | author name string | Dirk Dressler | |
| P433 | issue | 3 | |
| P304 | page(s) | 325-336 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Current Opinion in Microbiology | Q15752444 |
| P1476 | title | Clinical applications of botulinum toxin | |
| P478 | volume | 15 |
| Q36376074 | A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins. |
| Q39451452 | A brief history of neurological botulinum toxin therapy in Germany |
| Q41448985 | A chip-based assay for botulinum neurotoxin A activity in pharmaceutical preparations |
| Q35690475 | Activity of botulinum neurotoxin type D (strain 1873) in human neurons |
| Q35357741 | Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative |
| Q90230518 | Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches |
| Q55080639 | Antipruritic Effects of Botulinum Neurotoxins. |
| Q52773519 | Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons. |
| Q28660367 | Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm |
| Q33771420 | Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies |
| Q39207459 | Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology |
| Q38663243 | Botulinum Toxin A as an Adjunct to Abdominal Wall Reconstruction for Incisional Hernia. |
| Q51659874 | Botulinum neurotoxin A1 likes it double sweet. |
| Q38073580 | Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature |
| Q34614163 | Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction. |
| Q38631025 | Botulinum toxin drugs: brief history and outlook |
| Q38992567 | Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force. |
| Q35542237 | Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism |
| Q90390390 | Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy |
| Q37264589 | Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro |
| Q91815851 | Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins |
| Q26778129 | Current status and future directions of botulinum neurotoxins for targeting pain processing |
| Q50052256 | Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy |
| Q33608673 | Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy |
| Q61815956 | Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models |
| Q57177243 | Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity |
| Q64086211 | Entrapment Neuropathy: A Concept for Pathogenesis and Treatment of Headaches-A Narrative Review |
| Q55256497 | High resolution crystal structures of the receptor-binding domain of Clostridium botulinum neurotoxin serotypes A and FA. |
| Q34595178 | Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System |
| Q39010241 | Immunological aspects of botulinum toxin therapy |
| Q36315520 | In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5. |
| Q64228245 | Incisional hernia repair with plication and utilization of Botox injections: First case report from Saudi Arabia for a 19-year-old female |
| Q51462441 | Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A. |
| Q35108894 | Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells |
| Q26777632 | Pharmacotherapy for the management of achalasia: Current status, challenges and future directions |
| Q37147931 | Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety |
| Q48150203 | Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair |
| Q51276451 | Preoperative chemical component relaxation using Botulinum toxin A: enabling laparoscopic repair of complex ventral hernia. |
| Q49950077 | Preoperative combination of progressive pneumoperitoneum and botulinum toxin type A in patients with loss of domain hernia |
| Q64906017 | Primary resistance of human patients to botulinum neurotoxins A and B. |
| Q91994510 | Rapid Detection of Botulinum Neurotoxins-A Review |
| Q54337578 | Safety aspects of incobotulinumtoxinA high-dose therapy. |
| Q63753933 | Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain |
| Q36401493 | Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction |
| Q38113138 | The blockade of the neurotransmitter release apparatus by botulinum neurotoxins |
| Q42408273 | The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain |
| Q34313523 | The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals. |
| Q51112226 | The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders. |
| Q47830347 | Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series. |
| Q38232157 | Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. |
| Q38557101 | Using family and staff experiences of a botulinum toxin-A service to improve service quality |
Search more.